LobbyingBraidwood Management lobbying by quarter
Braidwood Management's latest lobbying report covers Q4 2024, at $6,000. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Braidwood Management
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $11.3K | 1 |
| Q1 2023 | $11.3K | 1 |
| Q2 2023 | $11.3K | 1 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $11.3K | 1 |
| Q1 2024 | $11.3K | 1 |
| Q2 2024 | $11.3K | 1 |
| Q3 2024 | $11.3K | 1 |
| Q4 2024 | $6,000 | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$28.3K · 8 reports
- Health issues$28.3K · 8 reports
- Pharmacy$28.3K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)8 reports
- HOUSE OF REPRESENTATIVES8 reports
- SENATE8 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rock & Associates | $84.8K | 8 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/02/02for Q4 2024 | Rock & Associates | $6,000 |
| 24/10/30for Q3 2024 | Rock & Associates | $11.3K |
| 24/09/09for Q4 2023 | Rock & Associates | $11.3K |
| 24/08/14for Q2 2024 | Rock & Associates | $11.3K |
| 24/05/08for Q1 2024 | Rock & Associates | $11.3K |
| 23/09/08for Q2 2023 | Rock & Associates | $11.3K |
| 23/05/11for Q1 2023 | Rock & Associates | $11.3K |
| 23/03/02for Q4 2022 | Rock & Associates | $11.3K |